EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Complement C3d enables cell-mediated immunity capable of distinguishing spontaneously transformed from nontransformed cells

Jeffrey L Platt iD, Chong Zhao, Jeffrey Chicca, Matthew J Pianko iD, Joshua Han, Stephanie The, Arvind Rao, Evan T Keller iD, Mayara Garcia de Mattos Barbosa iD, Lwar Naing, Tracy Pasieka-Axenov, Lev Axenov und 3 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2405824121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Jeffrey L Platt und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Michigan, Ann Arbor, MI 48109. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | National Institutes of Health (NIH), State of Michigan Economic Development Coorporation, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune surveillance depends in part on the recognition of peptide variants by T cell antigen receptors. Given that both normal B cells and malignant B cells accumulate mutations we chose a murine model of multiple myeloma to test conditions to induce cell-mediated immunity targeting malignant plasma cell (PC) clones but sparing of normal PCs. Revealing a previously unknown function for intracellular C3d, we found that C3d engaged T cell responses against malignant PC in the bone marrow of mice that had developed multiple myeloma spontaneously. Our results show that C3d internalized by cells augments immune surveillance by several mechanisms. In one, C3d induces a master transcription regulator, E2f1, to increase the expression of long noncoding (lnc) RNAs, to generate peptides for MHC-I presentation, and increase MHC-I expression. In another, C3d increases expression of RNAs encoding ribosomal proteins linked to processing of defective ribosomal products that arise from noncanonical translation and known to promote immunosurveillance. Cancer cells are uniquely susceptible to increased expression and presentation of mutant peptides given the extent of protein misfolding and accumulation of somatic mutations. Accordingly, although C3d can be internalized by any cell, C3d preferentially targets malignant clones by evoking specific T cell–mediated immunity and sparing most nontransformed polyclonal B cells and PC with lower mutation loads. Malignant PC deletion was blocked by cyclosporin or by CD8 depletion confirming that endogenous T cells mediated malignant clone clearance. Besides the potential for therapeutic application our results highlight how intracellular C3d modifies cellular metabolism to augment immune surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaAnimalsMiceImmunity, CellularPlasma CellsMice, Inbred C57BLT-LymphocytesRNA, Long NoncodingCell Transformation, Neoplastic

Stichwörter der Autor:innen

Cell-mediated immunityComplement 3 dimmune-surveillance

Substanzen

RNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Surgery, University of Michigan, Ann Arbor, MI 48109.
  • Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109.
  • Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109.
  • Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109.
  • Cancer Data Science Shared Research Core, University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109.
  • Department of Urology and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.

ORCID-Profile: Jeffrey L Platt, Matthew J Pianko, Evan T Keller, Mayara Garcia de Mattos Barbosa, Evan Farkash

Förderung

  • HHS | National Institutes of Health (NIH)
  • State of Michigan Economic Development Coorporation
  • NIA NIH HHS
  • U.S. Department of Defense (DOD)
  • NCI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Platt, J. L., Zhao, C., Chicca, J., Pianko, M. J., Han, J., The, S., Rao, A., Keller, E. T., Garcia de Mattos Barbosa, M., Naing, L., Pasieka-Axenov, T., Axenov, L., Schaefer, S., Farkash, E., & Cascalho, M. (2024). Complement C3d enables cell-mediated immunity capable of distinguishing spontaneously transformed from nontransformed cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2405824121

Vancouver

Platt JL, Zhao C, Chicca J, Pianko MJ, Han J, The S, et al. Complement C3d enables cell-mediated immunity capable of distinguishing spontaneously transformed from nontransformed cells. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2405824121

BibTeX
@article{Platt2024,
  author = {Platt, Jeffrey L and Zhao, Chong and Chicca, Jeffrey and Pianko, Matthew J and Han, Joshua and The, Stephanie and Rao, Arvind and Keller, Evan T and Garcia de Mattos Barbosa, Mayara and Naing, Lwar and Pasieka-Axenov, Tracy and Axenov, Lev and Schaefer, Simon and Farkash, Evan and Cascalho, Marilia},
  title = {Complement C3d enables cell-mediated immunity capable of distinguishing spontaneously transformed from nontransformed cells},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2405824121}
}
Kostenlos starten →